top of page
Executive Spotlights

Boston Scientific Announces a $1.6B Agreement to Acquire Silk Road Medical

Marlborough, MA, June 18, 2024 (PRNewswire) -- In a significant addition to its vascular portfolio, Boston Scientific is aqcuiring Silk Road Medical for approximately $1.6B specializing in non-invasive stroke prevention methods. The deal, adds a novel procedure for treating carotid artery conditions into the Boston Scientific's diverse medical offerings. This strategic acquisition is set to complete later this year, bolstering the company’s growth and enhancing its portfolio with a unique therapeutic approach.

Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial


Life Science Headlines
bottom of page